Literature DB >> 18367034

Diabetes mellitus, insulin resistance, hyperglycemia, and stroke.

Karen Furie1, Silvio E Inzucchi.   

Abstract

It is well established that diabetes is associated with an increased risk of stroke. Once a stroke has occurred, patients with diabetes experience poorer outcomes (functional status, mortality). Convincing data now support aggressive glucose control and comprehensive cardiovascular risk factor management to prevent stroke in patients with diabetes. However, there remains a distinct paucity of information concerning secondary stroke prevention. Hyperglycemia in the acute stroke setting is a marker for poor outcomes, but it remains unclear whether intensive in-hospital lowering of blood glucose levels improves clinical outcomes. Targeting insulin resistance as a modifiable risk factor for stroke is a novel strategy currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367034     DOI: 10.1007/s11910-008-0004-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  53 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 4.  The role of hyperglycemia in acute stroke.

Authors:  N Kagansky; S Levy; H Knobler
Journal:  Arch Neurol       Date:  2001-08

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

7.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

8.  Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes.

Authors:  Susan P Laing; Anthony J Swerdlow; Lucy M Carpenter; Stefan D Slater; Andrew C Burden; Johannes L Botha; Andrew D Morris; Norman R Waugh; Wendy Gatling; Edwin A M Gale; Christopher C Patterson; Zongkai Qiao; Harry Keen
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

9.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.

Authors:  Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Sten Madsbad
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

View more
  7 in total

1.  Impaired vascular responses of insulin-resistant rats after mild subarachnoid hemorrhage.

Authors:  Adam Institoris; James A Snipes; Prasad V Katakam; Ferenc Domoki; Krisztina Boda; Ferenc Bari; David W Busija
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

Review 2.  The diagnosis and management of cerebrovascular disease in diabetes.

Authors:  Michael S Phipps; Ania M Jastreboff; Karen Furie; Walter N Kernan
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 3.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

4.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

5.  Pharmacological inhibition of myostatin/TGF-β receptor/pSmad3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes.

Authors:  Jaemin Jeong; Michael J Conboy; Irina M Conboy
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

6.  Optimum control of blood glucose for prevention and treatment of ischemic and hemorrhagic stroke.

Authors:  Veronique Guyomard; Phyo Kyaw Myint
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-06

7.  Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.

Authors:  Odd Erik Johansen; Ellen Brustad; Steve Enger; Arnljot Tveit
Journal:  Cardiovasc Diabetol       Date:  2008-09-28       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.